Andelyn Biosciences to Implement Curator® Platform to Develop and Manufacture Gene Therapy AAV9-GM2 for Queen's University to Treat GM2 Gangliosidoses

One daysingle sourceOne outlet reported this, once - no second voice in this corpus.

All 1 reports on Tue, 18 August 2026

What it is about

Matt Niloff Jagdeep Walia Andelyn Biosciences Contract Development Linkedin United Nation Sustainable Development Goals Sdgs Queen University Department Of Pediatrics At Queen University Manufacturing Organization Columbus, Ohio, United States Canada Ohio, United States

Who published it, and when

How it spread - 1 original report

Tue, 18 August 2026
1 report
- prnewswire.com17:21first to report
  Andelyn Biosciences to Implement Curator® Platform to Develop and Manufacture Gene Therapy AAV9-GM2 for Queen's University to Treat GM2 Gangliosidoses
  /PRNewswire/ -- Andelyn Biosciences, Inc., a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has...